FDA Inspection 1107986 — King Pharmaceuticals LLC

King Pharmaceuticals LLC — FEI 1876582

The FDA completed an inspection of King Pharmaceuticals LLC on October 21, 2019 in Rochester, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 21, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MI (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed